Sunbird Bio is a diagnostics platform developer that aims to give molecular diagnostics with faster outcomes.
Sunbird Bio has raised $14.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2024.
Sunbird Bio's investors include Eli Lilly, Catalio Capital Management, Polaris Partners, S32, EDBI.
Sunbird Bio is headquartered in Singapore, Singapore.
Sunbird Bio is a diagnostics platform developer that aims to give molecular diagnostics with faster outcomes.
Sunbird Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sunbird Bio — Funding & Investors." VCBacked, October 16, 2024, https://www.vcbacked.co/company/sunbird-bio. Accessed October 26, 2026.
VCBacked. (2024). Sunbird Bio — Funding & Investors. Retrieved October 26, 2026, from https://www.vcbacked.co/company/sunbird-bio
{{cite web |title=Sunbird Bio — Funding & Investors |url=https://www.vcbacked.co/company/sunbird-bio |website=VCBacked |access-date=October 26, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated